Exact Mass: 545.1111

Exact Mass Matches: 545.1111

Found 39 metabolites which its exact mass value is equals to given mass value 545.1111, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

dTDP-beta-L-4-epi-vancosamine

dTDP-L-epivancosamine; dTDP-beta-L-4-epi-vancosamine; dTDP-3-amino-2,3,6-trideoxy-3-methyl-beta-L-arabino-hexopyranose

C17H29N3O13P2 (545.1176)

dTDP-beta-L-vancosamine

C17H29N3O13P2 (545.1176)

Alvelestat

C25H22F3N5O4S (545.1345)

COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

Alvelestat

N-((5-(Methanesulfonyl)pyridin-2-yl)methyl)-6-methyl-5-(1-methyl-1H-pyrazol-5-yl)-2-oxo-1-(3-(trifluoromethyl)phenyl)-1,2-dihydropyridine-3-carboxamide

C25H22F3N5O4S (545.1345)

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

5-{3-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetraazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-4-yl]prop-2-yn-1-yl}-5,6-dihydrophenanthridin-6-one

C31H20ClN5OS (545.1077)

Adafosbuvir

Propan-2-yl 2-[({[2-fluoro-3,4-dihydroxy-5-(4-hydroxy-2-oxo-1,2-dihydropyrimidin-1-yl)-4-methyloxolan-2-yl]methoxy}(phenoxy)phosphoryl)amino]propanoic acid

C22H29FN3O10P (545.1575)

N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)allylamino]-4-methoxyphenyl]acetamide

C21H20BrN7O6 (545.0658)

CP-945598 HCl

Otenabant hydrochloride

C25H26Cl3N7O (545.1264)

C78272 - Agent Affecting Nervous System > C29728 - Anorexiant

Ziprasidone Impurity E

C28H24ClN5OS2 (545.1111)

(2R)-2-[bis[3,5-bis(trifluoromethyl)phenyl]methyl]pyrrolidine,hydrochloride

C21H16ClF12N (545.078)

(S)-2-{Bis[3,5-bis(trifluoromethyl)phenyl]methyl}pyrrolidine hydrochloride

C21H16ClF12N (545.078)

C22H29ClN3O9P

C22H29ClN3O9P (545.133)

Uprifosbuvir

C22H29ClN3O9P (545.133)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

5-Chloro-N,N-bis[2-(ethoxy carbonyloxy) ethyl]-2-methoxy-4-(5-nitro-1,3-thiazol-2-ylazo) aniline

C20H24ClN5O9S (545.0983)

Adafosbuvir

Propan-2-yl 2-[[[5-(2,4-dioxopyrimidin-1-yl)-2-fluoro-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate

C22H29FN3O10P (545.1575)

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor

Gefapixant citrate

C20H27N5O11S (545.1428)

C78272 - Agent Affecting Nervous System > C177180 - P2X Purinoreceptor Antagonist

5-(3-(4-(2-Chlorophenyl)-9-methyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin-2-yl)-2-propynyl)phenanthridin-6(5H)-one

C31H20ClN5OS (545.1077)

afrormosin-7-O-glucoside-6-O-malonate

C26H25O13- (545.1295)

N-[[(4S,5S)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

C23H36BrN3O5S (545.1559)

N-[[(4S,5R)-8-bromo-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-N-methyl-3-(1-piperidinyl)propanamide

C23H36BrN3O5S (545.1559)

Xanthoaphin(1-)

C30H25O10- (545.1448)

(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxylatopropan-2-yl)oxy]imino}acetyl]amino}-8-oxo-3-(pyridinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

C22H21N6O7S2- (545.0913)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-(2,2,2-trifluoroethylsulfonyl)-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C20H30F3N3O7S2 (545.1477)

(3-5)-Uridylylcytidine

C20H28N5O11P (545.1523)

(3-5)-Cytidylyluridine

C20H28N5O11P (545.1523)

ceftazidime(1-)

C22H21N6O7S2 (545.0913)

A cephalosporin carboxylic acid anion formed by proton loss from the carboxy group of ceftazidime, a cephalosporin having 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-{[(2-carboxypropan-2-yl)oxy]imino}acetyl]amino and 3-pyridinium-1-ylmethyl side-groups.

CpU

C20H28N5O11P (545.1523)

UpC

C20H28N5O11P (545.1523)

8-{7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene}-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

C28H19NO11 (545.0958)

(3r)-8-[(3r)-7-amino-6,10-dihydroxy-3-methyl-1,9-dioxo-3h,4h-naphtho[2,3-c]pyran-8-ylidene]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,7,9-tetrone

C28H19NO11 (545.0958)

2,3,9,20,23,27-hexahydroxy-6-methoxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

C29H23NO10 (545.1322)

(2r,3s,4r,6r,7r,14s)-2,3,9,20,23,27-hexahydroxy-6-methoxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

(2r,3s,4r,6r,7r,14s)-2,3,9,20,23,27-hexahydroxy-6-methoxy-4-methyl-15-azaheptacyclo[14.12.0.0²,⁷.0³,¹⁴.0⁸,¹³.0¹⁷,²⁶.0¹⁹,²⁴]octacosa-1(16),8,10,12,17(26),19,21,23,27-nonaene-5,18,25-trione

C29H23NO10 (545.1322)

10-[5-(6-bromo-1h-indol-3-yl)-6-oxo-1h-pyrazin-2-yl]-1-hydroxy-4-imino-7-methyl-3,5,12-triazatetracyclo[6.6.1.0²,⁶.0⁹,¹³]pentadeca-2(6),9(13),10-trien-14-one

C25H20BrN7O3 (545.0811)

(3r)-7-amino-8-[(3r)-7,10-dihydroxy-3-methyl-1,6,9-trioxo-3h,4h-naphtho[2,3-c]pyran-8-yl]-10-hydroxy-3-methyl-3h,4h-naphtho[2,3-c]pyran-1,6,9-trione

C28H19NO11 (545.0958)